Louise St Germain Bannon Appointed Interim Executive Director of ISTH
Louise St Germain Bannon, Director of Membership, Marketing and External Relations of ISTH, reposted from ISTH on LinkedIn:
”I’m excited to support the International Society on Thrombosis and Haemostasis (ISTH) in this interim leadership role at such a dynamic moment for the Society.
The reason is simple: the extraordinary ISTH staff, volunteer leaders, partners and supporters who carry this organization forward every day.
Their dedication, expertise and collaboration are what make the ISTH impactful across more than 120 countries, and I’m deeply grateful for the opportunity to work alongside them.
I’m especially energized by the momentum across the Society and by what lies ahead as we move toward ISTH 2026 in Paris (July 11–15).
It’s shaping up to be an incredible moment for our global community to come together, share knowledge and continue advancing the field.
Thank you to our Council, leadership and global community for your trust and partnership.
I’m grateful and look forward to working together to advance our mission.”
Quoting International Society on Thrombosis and Haemostasis (ISTH)‘s post:
”Exciting news!
The International Society on Thrombosis and Haemostasis (ISTH) has appointed Louise St. Germain Bannon as Interim Executive Director. St. Germain brings more than 20 years of experience in global health marketing, communications and advocacy, and has led the ISTH’s marketing and communications programs since 2012.
Learn more here.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development
-
Oct 20, 2026, 03:13Sumyea Kabir: Pre-Analytical Quality in Phlebotomy – Preventing In Vitro Hemolysis
-
Oct 20, 2026, 02:37M. Sekip Altunkan: Can Anticoagulation Be Safely Stopped After AF Ablation?
-
Oct 20, 2026, 02:26Ahmed Ammar: Managing VT Recurrence Post-Ablation
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation